Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Gains from Sales and Divestitures (2022 - 2024)

Historic Gains from Sales and Divestitures for Generation Bio (GBIO) over the last 3 years, with Q4 2024 value amounting to $496782.0.

  • Generation Bio's Gains from Sales and Divestitures fell 3217.51% to $496782.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $496782.0, marking a year-over-year decrease of 3217.51%. This contributed to the annual value of $496782.0 for FY2024, which is 3217.51% down from last year.
  • Per Generation Bio's latest filing, its Gains from Sales and Divestitures stood at $496782.0 for Q4 2024, which was down 3217.51% from $732448.0 recorded in Q4 2023.
  • Generation Bio's Gains from Sales and Divestitures' 5-year high stood at $732448.0 during Q4 2023, with a 5-year trough of $496782.0 in Q4 2024.
  • For the 3-year period, Generation Bio's Gains from Sales and Divestitures averaged around $584131.7, with its median value being $523165.0 (2022).
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 4000.32% in 2023, then tumbled by 3217.51% in 2024.
  • Quarter analysis of 3 years shows Generation Bio's Gains from Sales and Divestitures stood at $523165.0 in 2022, then surged by 40.0% to $732448.0 in 2023, then tumbled by 32.18% to $496782.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $496782.0 for Q4 2024, versus $732448.0 for Q4 2023 and $523165.0 for Q4 2022.